Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Aspirin may help slow down colorectal cancer evolution
Cancer starts when cells start dividing uncontrollably. Scientists have known that taking aspirin can help…
New nano-gel to protect children receiving chemotherapy from hearing loss
Curtin University researchers will test a new nano-gel they have created to protect children receiving…
AI system that mimics human gaze could be used to detect cancer
A cutting-edge artificial intelligence (AI) system that can accurately predict the areas of an image…
EBCC 2022: Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years
- EBCC 2022: More cancers are diagnosed at an advanced stage if patients already have type 2 diabetes
- EBCC 2022: Gradual increase in daily activity with psychological therapies can improve mental health for cancer patients and survivors
- Popular dietary supplement increases breast cancer risk, brain metastasis
One test to diagnose them all: researchers exploit cancers’ unique DNA signature
Abu Sina, The University of Queensland; Laura G. Carrascosa, The University of Queensland, and Matt Trau, The University of Queensland…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.